{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:58:41Z","timestamp":1790711921288,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.phymed.2022.154444","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T06:54:59Z","timestamp":1662447299000},"page":"154444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Astragaloside IV ameliorates diet-induced hepatic steatosis in obese mice by inhibiting intestinal FXR via intestinal flora remodeling"],"prefix":"10.1016","volume":"107","author":[{"given":"Yuanyuan","family":"Zhai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenling","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jizhi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8377-0833","authenticated-orcid":false,"given":"Liang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.phymed.2022.154444_bib0001","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1136\/gutjnl-2016-312975","article-title":"Fibroblast growth factor 15\/19 (FGF15\/19) protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regeneration","volume":"66","author":"Alvarez-Sola","year":"2017","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.phymed.2022.154444_bib0002","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1053\/j.gastro.2020.01.049","article-title":"Nonalcoholic fatty liver disease: modulating gut microbiota to improve severity?","volume":"158","author":"Aron-Wisnewsky","year":"2020","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.phymed.2022.154444_bib0003","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/j.gastro.2012.04.001","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology","volume":"142","author":"Chalasani","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phymed.2022.154444_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.etap.2020.103397","article-title":"Astragaloside IV suppresses development of hepatocellular carcinoma by regulating miR-150-5p\/beta-catenin axis","volume":"78","author":"Cui","year":"2020","journal-title":"Environ. Toxicol. Pharmacol."},{"issue":"6","key":"10.1016\/j.phymed.2022.154444_bib0005","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.apsb.2021.03.038","article-title":"Notoginsenoside Ft1 acts as a TGR5 agonist but FXR antagonist to alleviate high fat diet-induced obesity and insulin resistance in mice","volume":"11","author":"Ding","year":"2021","journal-title":"Acta Pharm. Sin B"},{"issue":"11","key":"10.1016\/j.phymed.2022.154444_bib0006","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.molmed.2015.09.001","article-title":"Bile acid-activated receptors, intestinal microbiota, and the treatment of metabolic disorders","volume":"21","author":"Fiorucci","year":"2015","journal-title":"Trends Mol. Med."},{"issue":"4","key":"10.1016\/j.phymed.2022.154444_bib0007","first-page":"308","article-title":"The human gut microbiota: metabolism and perspective in obesity","volume":"9","author":"Gomes","year":"2018","journal-title":"Gut Microbes"},{"issue":"16","key":"10.1016\/j.phymed.2022.154444_bib0008","doi-asserted-by":"crossref","first-page":"9349","DOI":"10.1111\/jcmm.15586","article-title":"Astragaloside IV alleviates mouse slow transit constipation by modulating gut microbiota profile and promoting butyric acid generation","volume":"24","author":"He","year":"2020","journal-title":"J. Cell. Mol. Med."},{"issue":"1","key":"10.1016\/j.phymed.2022.154444_bib0009","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1038\/s41467-019-12896-x","article-title":"Theabrownin from Pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism","volume":"10","author":"Huang","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.phymed.2022.154444_bib0010","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1172\/JCI76738","article-title":"Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease","volume":"125","author":"Jiang","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phymed.2022.154444_bib0011","doi-asserted-by":"crossref","first-page":"10166","DOI":"10.1038\/ncomms10166","article-title":"Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction","volume":"6","author":"Jiang","year":"2015","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.phymed.2022.154444_bib0012","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/hep.25740","article-title":"Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice","volume":"56","author":"Kong","year":"2012","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.phymed.2022.154444_bib0013","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1136\/gutjnl-2012-303816","article-title":"Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice","volume":"62","author":"Le Roy","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.phymed.2022.154444_bib0014","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1038\/ncomms3384","article-title":"Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity","volume":"4","author":"Li","year":"2013","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.phymed.2022.154444_bib0015","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/hep.24107","article-title":"Overexpression of cholesterol 7alpha-hydroxylase promotes hepatic bile acid synthesis and secretion and maintains cholesterol homeostasis","volume":"53","author":"Li","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.phymed.2022.154444_bib0016","article-title":"Astragaloside IV Improves High-Fat Diet-Induced Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Rats by Regulating Inflammatory Factors Level via TLR4\/NF-kappaB Signaling Pathway","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2022.154444_bib0017","doi-asserted-by":"crossref","DOI":"10.1096\/fj.201903102RR","article-title":"Neohesperidin attenuates obesity by altering the composition of the gut microbiota in high-fat diet-fed mice","author":"Lu","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.phymed.2022.154444_bib0018","first-page":"160","article-title":"A review of saponin intervention in metabolic syndrome suggests further study on intestinal microbiota","author":"Luo","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"5418","key":"10.1016\/j.phymed.2022.154444_bib0019","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","article-title":"Identification of a nuclear receptor for bile acids","volume":"284","author":"Makishima","year":"1999","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.phymed.2022.154444_bib0020","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tem.2017.11.002","article-title":"Role of Bile Acids in Metabolic Control","volume":"29","author":"Molinaro","year":"2018","journal-title":"Trends Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.phymed.2022.154444_bib0021","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/gutjnl-2015-310283","article-title":"Microbiota-induced obesity requires farnesoid X receptor","volume":"66","author":"Parseus","year":"2017","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.phymed.2022.154444_bib0022","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/hep.29857","article-title":"Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism","volume":"68","author":"Pathak","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.phymed.2022.154444_bib0023","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.freeradbiomed.2016.11.037","article-title":"Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation","volume":"102","author":"Porras","year":"2017","journal-title":"Free Radic. Biol. Med."},{"issue":"7","key":"10.1016\/j.phymed.2022.154444_bib0024","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.cgh.2013.02.015","article-title":"Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease","volume":"11","author":"Raman","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"11","key":"10.1016\/j.phymed.2022.154444_bib0025","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nrgastro.2013.197","article-title":"NAFLD-the next global epidemic","volume":"10","author":"Ray","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"6150","key":"10.1016\/j.phymed.2022.154444_bib0026","doi-asserted-by":"crossref","DOI":"10.1126\/science.1241214","article-title":"Gut microbiota from twins discordant for obesity modulate metabolism in mice","volume":"341","author":"Ridaura","year":"2013","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.phymed.2022.154444_bib0027","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41575-019-0144-8","article-title":"Past, present and future perspectives in nonalcoholic fatty liver disease","volume":"16","author":"Sanyal","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.phymed.2022.154444_bib0028","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","article-title":"Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist","volume":"17","author":"Sayin","year":"2013","journal-title":"Cell Metab."},{"issue":"10","key":"10.1016\/j.phymed.2022.154444_bib0029","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/nm.4185","article-title":"Signals from the gut microbiota to distant organs in physiology and disease","volume":"22","author":"Schroeder","year":"2016","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.phymed.2022.154444_bib0030","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cmet.2020.11.010","article-title":"Current concepts, opportunities, and challenges of gut microbiome-based personalized medicine in nonalcoholic fatty liver disease","volume":"33","author":"Sharpton","year":"2021","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.phymed.2022.154444_bib0031","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/imr.12856","article-title":"Microbiome, bile acids, and obesity: how microbially modified metabolites shape anti-tumor immunity","volume":"295","author":"Sipe","year":"2020","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.phymed.2022.154444_bib0032","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40168-019-0628-3","article-title":"Taxonomic profiling and populational patterns of bacterial bile salt hydrolase (BSH) genes based on worldwide human gut microbiome","volume":"7","author":"Song","year":"2019","journal-title":"Microbiome"},{"issue":"9","key":"10.1016\/j.phymed.2022.154444_bib0033","doi-asserted-by":"crossref","first-page":"5568","DOI":"10.1021\/jf9042634","article-title":"Study on the relevance between beany flavor and main bioactive components in radix astragali","volume":"58","author":"Sun","year":"2010","journal-title":"J. Agric. Food Chem."},{"issue":"4","key":"10.1016\/j.phymed.2022.154444_bib0034","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.apsb.2019.02.004","article-title":"Ablation of gut microbiota alleviates obesity-induced hepatic steatosis and glucose intolerance by modulating bile acid metabolism in hamsters","volume":"9","author":"Sun","year":"2019","journal-title":"Acta Pharm. Sin B"},{"issue":"12","key":"10.1016\/j.phymed.2022.154444_bib0035","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/s41591-018-0222-4","article-title":"Gut microbiota and intestinal FXR mediate the clinical benefits of metformin","volume":"24","author":"Sun","year":"2018","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.phymed.2022.154444_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109641","article-title":"Myricetin supplementation decreases hepatic lipid synthesis and inflammation by modulating gut microbiota","volume":"36","author":"Sun","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.phymed.2022.154444_bib0037","doi-asserted-by":"crossref","first-page":"7629","DOI":"10.1038\/ncomms8629","article-title":"Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells","volume":"6","author":"Trabelsi","year":"2015","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.phymed.2022.154444_bib0038","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1172\/JCI21025","article-title":"Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c","volume":"113","author":"Watanabe","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phymed.2022.154444_bib0039","doi-asserted-by":"crossref","first-page":"30190","DOI":"10.1038\/srep30190","article-title":"Astragaloside IV improves lipid metabolism in obese mice by alleviation of leptin resistance and regulation of thermogenic network","volume":"6","author":"Wu","year":"2016","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.phymed.2022.154444_bib0040","first-page":"131","article-title":"Suppressing the intestinal farnesoid X receptor\/sphingomyelin phosphodiesterase 3 axis decreases atherosclerosis","author":"Wu","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.phymed.2022.154444_bib0041","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/gutjnl-2017-315458","article-title":"Gut commensal Parabacteroides goldsteinii plays a predominant role in the anti-obesity effects of polysaccharides isolated from Hirsutella sinensis","volume":"68","author":"Wu","year":"2019","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.phymed.2022.154444_bib0042","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1074\/jbc.M109.068783","article-title":"FGF19-induced hepatocyte proliferation is mediated through FGFR4 activation","volume":"285","author":"Wu","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.phymed.2022.154444_bib0043","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2337\/db16-0663","article-title":"An Intestinal Farnesoid X Receptor-Ceramide Signaling Axis Modulates Hepatic Gluconeogenesis in Mice","volume":"66","author":"Xie","year":"2017","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.phymed.2022.154444_bib0044","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41419-020-02974-0","article-title":"The triterpenoid sapogenin (2alpha-OH-Protopanoxadiol) ameliorates metabolic syndrome via the intestinal FXR\/GLP-1 axis through gut microbiota remodelling","volume":"11","author":"Xie","year":"2020","journal-title":"Cell Death. Dis."},{"issue":"11","key":"10.1016\/j.phymed.2022.154444_bib0045","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.2337\/db14-0263","article-title":"SIRT1 mediates the effect of GLP-1 receptor agonist exenatide on ameliorating hepatic steatosis","volume":"63","author":"Xu","year":"2014","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.phymed.2022.154444_bib0046","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1007\/s12275-018-8327-5","article-title":"Astragaloside IV reversed the autophagy and oxidative stress induced by the intestinal microbiota of AIS in mice","volume":"56","author":"Xu","year":"2018","journal-title":"J. Microbiol."},{"key":"10.1016\/j.phymed.2022.154444_bib0047","first-page":"120","article-title":"Fenofibrate, a PPAR\u03b1 agonist, reduces hepatic fat accumulation through the upregulation of TFEB-mediated lipophagy","author":"Yoo","year":"2021","journal-title":"Metabolism"},{"issue":"6","key":"10.1016\/j.phymed.2022.154444_bib0048","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.phymed.2022.154444_bib0049","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease - A global public health perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.phymed.2022.154444_bib0050","doi-asserted-by":"crossref","first-page":"eaax6208","DOI":"10.1126\/sciadv.aax6208","article-title":"Citrus polymethoxyflavones attenuate metabolic syndrome by regulating gut microbiome and amino acid metabolism","volume":"6","author":"Zeng","year":"2020","journal-title":"Sci. Adv."},{"issue":"4","key":"10.1016\/j.phymed.2022.154444_bib0051","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.cmet.2020.11.017","article-title":"Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism","volume":"33","author":"Zheng","year":"2021","journal-title":"Cell Metab."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711322005335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711322005335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T18:40:29Z","timestamp":1760553629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711322005335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":51,"alternative-id":["S0944711322005335"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2022.154444","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Astragaloside IV ameliorates diet-induced hepatic steatosis in obese mice by inhibiting intestinal FXR via intestinal flora remodeling","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2022.154444","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"154444"}}